Atlas Trials

Predictive Factors for Successful Outcome After Pulmonary Veins Ablation to Treat Paroxysmal Atrial Fibrillation

Clinical trial NCT02614521 · WITHDRAWN

Trial details

NCT number
NCT02614521
Sponsor
Elpen Pharmaceutical Co. Inc.
Status
WITHDRAWN
Study type
OBSERVATIONAL
Atrial Fibrillation
Start date
2017-01-01
Primary completion
2019-02-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.